Shortened PQ interval in the differential diagnosis of Anderson-Fabry disease: a case report
P. D. Zlobina,
A. A. Kalemberg,
R. P. Myasnikov,
M. S. Kharlap,
O. V. Kulikova,
E. A. Mershina,
A. V. Tarasov,
K. V. Davtyan https://doi.org/10.15829/1560-4071-2022-5123
Abstract
In this article, we present a case of a patient with a late diagnosis of Fabry disease caused by a pathogenic variant in the GLA gene (p.1287_1288dup), who repeatedly attempted interventional treatment of Wolff-Parkinson-White Syndrome due to characteristic electrocardiographic pattern of ventricular preexcitation and paroxysmal arrhythmias. The proposed pathognomonic signs of the disease will ensure timely diagnosis and the appointment of specific treatment.
About the Authors
P. D. Zlobina
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
none
A. A. Kalemberg
M.F. Vladimirsky Moscow Regional Research Clinical Institute
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
none
R. P. Myasnikov
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
none
M. S. Kharlap
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
none
O. V. Kulikova
ФГБУ Национальный медицинский исследовательский центр терапии и профилактической медицины Минздрава России
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
none
E. A. Mershina
Lomonosov Moscow State University
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
none
A. V. Tarasov
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
none
K. V. Davtyan
National Medical Research Center for Therapy and Preventive Medicine
Russian Federation
Competing Interests:
Russian Federation
Moscow
Competing Interests:
none
References
1. Myasnikov RP, Andreenko EY, Kushunina DV, et al. Cardiac amyloidosis: Modern aspects of diagnosis and treatment (clinical observation). Clinical and Experimental Surgery. 2014;4(6):72-82. (In Russ.)
2. Linhart A, Elliott PM. The heart in Anderson-Fabry disease and other lysosomal storage disorders. Heart. 2007;93(4):528-35. doi:10.1136/hrt.2005.063818.
3. Steare SE, Dubowitz V, Benatar A. Subclinical cardiomyopathy in Becker muscular dystrophy. Br Heart J. 1992;68(3):304-8. doi:10.1136/hrt.68.9.304.
4. Pieroni M, Moon JC, Arbustini E, et al. Cardiac Involvement in Fabry Disease: JACC Review Topic of the Week. J Am Coll Cardiol. 2021;77(7):922-36. doi:10.1016/j.jacc.2020.12.024.
5. Namdar M. Electrocardiographic Changes and Arrhythmia in Fabry Disease. Front Cardiovasc Med. 2016;3:7. doi:10.3389/fcvm.2016.00007.
6. Birket MJ, Raibaud S, Lettieri M, et al. A Human Stem Cell Model of Fabry Disease Implicates LIMP-2 Accumulation in Cardiomyocyte Pathology. Stem Cell Reports. 2019;13(2):380-93. doi:10.1016/j.stemcr.2019.07.004.
7. Motwani M, Banypersad S, Woolfson P, et al. Enzyme replacement therapy improves cardiac features and severity of Fabry disease. Mol Genet Metab. 2012;107(1-2):197-202. doi:10.1016/j.ymgme.2012.05.011.
8. Kharlap MS, Myasnikov RP, Pavlunina TО, et al. Cardiac phenotype of Fabry Disease. Russian Journal of Cardiology. 2018;(7):80-3. (In Russ.) doi:10.15829/1560-4071-2018-7-80-83.
Supplementary files
Review
For citations:
Zlobina P.D., Kalemberg A.A., Myasnikov R.P., Kharlap M.S., Kulikova O.V., Mershina E.A., Tarasov A.V., Davtyan K.V. Shortened PQ interval in the differential diagnosis of Anderson-Fabry disease: a case report. Russian Journal of Cardiology. 2022;27(7):5123. (In Russ.) https://doi.org/10.15829/1560-4071-2022-5123
Views:
73255
Email this article 